Marc Bogdanowicz habla sobre la presencia asiática en general y china en particular en España y en Europa y se pregunta si vienen los chinos o ya estaban aquí.
Presentation given by Emmanuelle Guyavarch and Erwan Le Méner, France, at a FEANTSA Research Conference on "Migration, Homelessness and Demographic Change in Europe", Pisa, Italy, 2011
Seminário Nacional do Benzeno (5 e 6 de dez/12) - Derivação de Limites de Exposição Ocupacional para Substâncias Carcinogênicas e
Mutagênicas - Experiências Internacionais e Nacional
Presentation given by Emmanuelle Guyavarch and Erwan Le Méner, France, at a FEANTSA Research Conference on "Migration, Homelessness and Demographic Change in Europe", Pisa, Italy, 2011
Seminário Nacional do Benzeno (5 e 6 de dez/12) - Derivação de Limites de Exposição Ocupacional para Substâncias Carcinogênicas e
Mutagênicas - Experiências Internacionais e Nacional
en una época de cambios como la que vivimos, el rol del docente debe redefinirse hacia la búsqueda de un profesional dinámico y plástico, que se adapte a la mayor cantidad posible de situaciones y personas, y que forme a los mejores ciudadanos posibles para la construcción de un mundo mejor y un futuro sostenible y sustentable
en una época de cambios como la que vivimos, el rol del docente debe redefinirse hacia la búsqueda de un profesional dinámico y plástico, que se adapte a la mayor cantidad posible de situaciones y personas, y que forme a los mejores ciudadanos posibles para la construcción de un mundo mejor y un futuro sostenible y sustentable
Algunas imagenes de la noche inaugural y las obras en exhibición de Huellas V presentada por Ariela Naftal y Silvia Brewda en Objeto a.
Para mayor información consultar: www.objeto-a.com.ar
info@objeto-a.com.ar
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
Normal Labour/ Stages of Labour/ Mechanism of LabourWasim Ak
Normal labor is also termed spontaneous labor, defined as the natural physiological process through which the fetus, placenta, and membranes are expelled from the uterus through the birth canal at term (37 to 42 weeks
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Marc Bogdanowicz: ¿Que vienen los chinos?
1. ¿Vienen los Chinos?
Debates sobre tendencias de la sociedad de la información y el conocimiento - Sevilla, 9 abril 2013
1
2. SIC
Debates sobre tendencias de la
sociedad de la información y el
conocimiento
Sevilla, 9 de Abril 2013
¿Vienen los Chinos?
Marc Bogdanowicz Jean-Paul Simon
Institute for Prospective Technological Studies jps public policy consulting
Joint Research Centre - European Commission Paris - Seville
www.jrc.es / is.jrc.es
Disclaimer: The views expressed are those of the presenter and may not in any circumstances be regarded as stating an official position of the European
Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of this
presentation. 2
3. Tres fuerzas impulsadoras de cambio en Europa :
Globalización => emergencia de nuevas economías
Industria < Servicios
TIC como Tecnología de Ámbito General (GPT)
3
4. Globalización => emergencia de otras economías
Regional shares in World’s GDP (1980-2012)
4
Acknowledgement: Alain Stekke Data source: IMF, World Economic Outlook Database
5. Globalización => (re)emergencia de Asia
Regional shares in World’s GDP & per capita GDP (0-2012)
100% 7000 A fric a
O t h e r A s ia
6000
80% In d ia
5000 C h in a
60% Ja p a n
4000
L a t in A m e ric a
3000
40% W e s t e rn
O ffs h o t s
2000 F o rm e r U S S R
20% E -E u ro p e
1000
W -E u ro p e
0% 0 W o rld :
0 1000 1500 1870 1913 1950 1973 1998 2008 2013 G D P p c (R h s )
S o u rc e : A u t h o r's c o m p u t a t io n o n M a d d is o n (2 0 0 1 ) a n d IM F (2 0 0 8 )
5
Acknowledgement: Andrea de Panizza
7. Quand la Chine s'éveillera, le monde tremblera. Napoléon, 1816
Blade Runner, 1982
Les Chinois a Paris, 1974 Bienvenido,
Mister Marshall, 1953
8. China: El pais mas poblado, y pronto, el mayor GDP
2012 (est.) M US Dollars
World 71,620,000
k European Union 16,190,000
1 United States 15,650,000
2 China 8,250,000
3 Japan 5,984,000
4 Germany 3,367,000
5 France 2,580,000
6 United Kingdom 2,434,000
7 Brazil 2,425,000
8 Italy 1,980,000
9 Russia 1,954,000
10 India 1,947,000
11 Canada 1,770,000
12 Australia 1,542,000
13 Spain 1,340,000
Rank US dolllars/y
6 USA 48,328
28 Spain 30,478
93 China 8,387
Source: IMF, CIA factbook 8
10. China / Alemania
Un Aleman …
- spends 16 times more money on health care. Per capita public and private health
expenditures combined in Germany are $3,465 USD while China spends $216 USD
- consumes 5.2 times more oil. Germany consumes 1.3113 gallons of oil per day per
capita while China consumes 0.2526
- makes 5.2 times more money. The GDP per capita in Germany is $34,100 while in
China it is $6,600
- uses 2.6 times more electricity. The per capita consumption of electricity in
Germany is 6,651kWh while in China it is 2,585kWh.
- has 90.7% more chance of being unemployed. Germany has an unemployment rate
of 8.20% while China has 4.30%
- has 76.08% less chance of dying in infancy. The number of deaths of infants under
one year old in a given year per 1,000 live births in Germany is 3.95 while in China it
is 16.51.
- experiences 34.94% less of a class divide. The GINI index measures the degree of
inequality in the distribution of family income. In Germany is 27.00 while in China it is
41.50.
- has 32.54% less babies. The annual number of births per 1,000 people in Germany
is 8.21 while in China it is 12.17.
- live 4.9 years longer Source: http://www.ifitweremyhome.com/compare/CN/DE
10
14. Pero también un país con retos inmensos…
Costes energéticos
Acceso a materias primas
Desacuerdos comerciales
Polución y salud publica
Encarecimiento de los sueldos
Y mas…. 14
20. Tres preguntas – Múltiples respuestas…
¿ Como resolverán los Chinos su situación ?
¿ Nos cambiara la vida ?
¿ Cuál es nuestro papel en el proceso ?
20
21. SIC
Debates sobre tendencias de la
sociedad de la información y el
conocimiento
Sevilla, 9 abril 2013
No os perdéis:
1. The World innovation landscape: Asia rising? R, Veugelers BURUEGEL, 2013
2. Structural change in China, P.Ehmer, Deutsche Bank Research
3. The ICT Landscape in BRICS Countries: China, JP Simon, IPTS
And…grateful acknowledgement to the following
references:
CIA, CISCO, IMF, IPTS, jps public policy consulting SERI,
United Nations, Wikipedia, World Bank, etc.
Disclaimer: The views expressed are those of the presenter and may not in any circumstances be regarded as stating an official position of the European
Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of this
presentation. 21